Presentation TCT 2017 Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials? Presenter: Angeles Alonso Garcia November 01, 2017
Presentation CHIP Seattle 2017 The Growing Population of Heart Failure and Care Variability Presenter: Claudius Mahr August 10, 2017
Presentation CHIP Seattle 2017 Ischemic Cardiomyopathy: Medical Therapy and Devices Presenter: Ryan C. Martin August 10, 2017
Presentation AHA 2016 Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF) Presenter: Dirk J. van Veldhuisen November 16, 2016
Presentation TCT 2016 Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical) Presenter: Emerson C. Perin, William T. Abraham November 01, 2016
Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2014 Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization Presenter: Steven R. Bailey, Surya Dharma September 14, 2014
Presentation TCT 2012 REOPEN-AMI: A Prospective, Randomized Trial of Intracoronary Adenosine and Nitroprusside in Patients with ST-Segment Elevation Myocardial Infarction Presenter: Niccoli Giampaolo October 22, 2012